Viking Therapeutics, Inc. - 8-K Filing
Viking Therapeutics announced positive top-line results showing VK2735 maintained up to 97% of initial weight loss with every-other-week dosing and 90% with monthly dosing. (Items: 8.01 Other Events, 9.01 Financial Statements and Exhibits)
Tickers: $VKTX